Literature DB >> 12522069

Involvement of tachykinin receptors in Clostridium perfringens beta-toxin-induced plasma extravasation.

Masahiro Nagahama1, Shinsuke Morimitsu, Atsushi Kihara, Masahiko Akita, Koujun Setsu, Jun Sakurai.   

Abstract

1 Clostridium perfringens beta-toxin causes dermonecrosis and oedema in the dorsal skin of animals. In the present study, we investigated the mechanisms of oedema induced by the toxin. 2 The toxin induced plasma extravasation in the dorsal skin of Balb/c mice. 3 The extravasation was significantly inhibited by diphenhydramine, a histamine 1 receptor antagonist. However, the toxin did not cause the release of histamine from mouse mastocytoma cells. 4 Tachykinin NK(1) receptor antagonists, [D-Pro(2), D-Trp(7,9)]-SP, [D-Pro(4), D-Trp(7,9)]-SP and spantide, inhibited the toxin-induced leakage in a dose-dependent manner. Furthermore, the non-peptide tachykinin NK(1) receptor antagonist, SR140333, markedly inhibited the toxin-induced leakage. 5 The leakage induced by the toxin was markedly reduced in capsaicin-pretreated mouse skin but the leakage was not affected by systemic pretreatment with a calcitonin gene-related peptide receptor antagonist (CGRP(8-37)). 6 The toxin-induced leakage was significantly inhibited by the N-type Ca(2+) channel blocker, omega-conotoxin MVIIA, and the bradykinin B(2) receptor antagonist, HOE140 (D-Arg-[Hyp(3), Thi(5), D-Tic(7), Oic(8)]-bradykinin), but was not affected by the selective L-type Ca(2+) channel blocker, verapamil, the P-type Ca(2+) channel blocker, omega-agatoxin IVA, tetrodotoxin (TTX), the TTX-resistant Na(+) channel blocker, carbamazepine, or the sensory nerve conduction blocker, lignocaine. 7 These results suggest that plasma extravasation induced by beta-toxin in mouse skin is mediated via a mechanism involving tachykinin NK(1) receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522069      PMCID: PMC1573648          DOI: 10.1038/sj.bjp.0705022

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

Review 1.  Vanilloid (Capsaicin) receptors and mechanisms.

Authors:  A Szallasi; P M Blumberg
Journal:  Pharmacol Rev       Date:  1999-06       Impact factor: 25.468

Review 2.  Clostridial enteric diseases of domestic animals.

Authors:  J G Songer
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Clostridium perfringens beta-toxin forms multimeric transmembrane pores in human endothelial cells.

Authors:  V Steinthorsdottir; H Halldórsson; O S Andrésson
Journal:  Microb Pathog       Date:  2000-01       Impact factor: 3.738

4.  Clostridium perfringens beta-toxin is sensitive to thiol-group modification but does not require a thiol group for lethal activity.

Authors:  M Nagahama; A Kihara; T Miyawaki; M Mukai; Y Sakaguchi; S Ochi; J Sakurai
Journal:  Biochim Biophys Acta       Date:  1999-05-31

5.  Involvement of sensory neuropeptides in the development of plasma extravasation in rat dorsal skin following thermal injury.

Authors:  L Siney; S D Brain
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

6.  A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons.

Authors:  A N Akopian; L Sivilotti; J N Wood
Journal:  Nature       Date:  1996-01-18       Impact factor: 49.962

7.  Phoneutria nigriventer spider venom induces oedema in rat skin by activation of capsaicin sensitive sensory nerves.

Authors:  S K Costa; G de Nucci; E Antunes; S D Brain
Journal:  Eur J Pharmacol       Date:  1997-11-27       Impact factor: 4.432

Review 8.  Neurogenic vasodilatation and plasma leakage in the skin.

Authors:  P Holzer
Journal:  Gen Pharmacol       Date:  1998-01

9.  A non-pungent resiniferatoxin analogue, phorbol 12-phenylacetate 13 acetate 20-homovanillate, reveals vanilloid receptor subtypes on rat trigeminal ganglion neurons.

Authors:  L Liu; A Szallasi; S A Simon
Journal:  Neuroscience       Date:  1998-05       Impact factor: 3.590

10.  The effect of a tachykinin NK1 receptor antagonist, SR140333, on oedema formation induced in rat skin by venom from the Phoneutria nigriventer spider.

Authors:  R T Palframan; S K Costa; P Wilsoncroft; E Antunes; G de Nucci; S D Brain
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more
  12 in total

Review 1.  Recent progress in understanding the pathogenesis of Clostridium perfringens type C infections.

Authors:  F A Uzal; B A McClane
Journal:  Vet Microbiol       Date:  2011-02-26       Impact factor: 3.293

2.  Cloning of alpha-beta fusion gene from Clostridium perfringens and its expression.

Authors:  Jia-Ning Bai; Yan Zhang; Bao-Hua Zhao
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

Review 3.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

Review 4.  Comparative pathogenesis of enteric clostridial infections in humans and animals.

Authors:  Francisco A Uzal; Mauricio A Navarro; Jihong Li; John C Freedman; Archana Shrestha; Bruce A McClane
Journal:  Anaerobe       Date:  2018-06-05       Impact factor: 3.331

5.  Molecular Evolutionary Constraints that Determine the Avirulence State of Clostridium botulinum C2 Toxin.

Authors:  A Prisilla; R Prathiviraj; P Chellapandi
Journal:  J Mol Evol       Date:  2017-04-05       Impact factor: 2.395

Review 6.  Animal models to study the pathogenesis of human and animal Clostridium perfringens infections.

Authors:  Francisco A Uzal; Bruce A McClane; Jackie K Cheung; James Theoret; Jorge P Garcia; Robert J Moore; Julian I Rood
Journal:  Vet Microbiol       Date:  2015-02-25       Impact factor: 3.293

7.  The p38 MAPK and JNK pathways protect host cells against Clostridium perfringens beta-toxin.

Authors:  Masahiro Nagahama; Masahiro Shibutani; Soshi Seike; Mami Yonezaki; Teruhisa Takagishi; Masataka Oda; Keiko Kobayashi; Jun Sakurai
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

8.  Involvement of tumour necrosis factor-alpha in Clostridium perfringens beta-toxin-induced plasma extravasation in mice.

Authors:  M Nagahama; A Kihara; H Kintoh; M Oda; J Sakurai
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

9.  Clostridium Perfringens Toxins Involved in Mammalian Veterinary Diseases.

Authors:  F A Uzal; J E Vidal; B A McClane; A A Gurjar
Journal:  Open Toxinology J       Date:  2010

Review 10.  Clostridium perfringens epsilon toxin: a malevolent molecule for animals and man?

Authors:  Bradley G Stiles; Gillian Barth; Holger Barth; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2013-11-12       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.